Baccarat, BioAlliance Pharma, Valeo: French Equity Preview

Shares in the following companies may have unusual moves in Paris trading. Stock symbols are in parentheses and prices are from the last close.

France’s CAC 40 Index fell 1.6 percent to 2,935.82. The broader SBF 120 Index fell 1.4 percent to 2,259.25.

Baccarat (BCRA) SA: The crystal manufacturer said its swung to a first-half net profit of 900,000 euros from a 611,000 euro year-ago loss. The shares rose 0.1 percent to 140.0 euros.

BioAlliance Pharma SA (BIO) : The cancer drug developer said it had a first-half loss of 8.75 million euros, compared with net income of 10.58 million euros a year earlier. The shares fell 1.8 percent to 3.36 euros.

Neurones (NRO) SA: The computer services company said first-half operating profit rose to 12.6 million euros from 10 million euros. The shares rose 0.4 percent to 7.28 euros.

Valeo SA (FR) : The car parts maker said it bought back 558,302 shares at average price of 33.14 euros to cover bonuses and stock options plans. The shares fell 5 percent to 34.44 euros.

Vinci SA (DG) : The construction company said it and Dutch builder Royal BAM Groep NV have finalized the financing for updating a section of the Berlin to Munich highway, a 220 million euro project. The shares fell 1.1 percent to 32.79 euros.

To contact the reporter on this story: Gregory Viscusi in Paris at gviscusi@bloomberg.net Marthe Fourcade in Paris at mfourcade@bloomberg.net

To contact the editor responsible for this story: Andrew Rummer at arummer@bloomberg.net

Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.